Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model

Radioimmunotherapy is considered as treatment option in recurrent and/or refractory B-cell non-Hodgkin lymphoma (B-NHL). To overcome the dose limiting bone marrow toxicity of IgG-based radioimmunoconjugates (RICs), we modified a humanized diabody with 5-, 10-, or 20-kDa polyethylene glycol (PEG) for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weber, Tobias (VerfasserIn) , Bötticher, Benedikt (VerfasserIn) , Arndt, Michaela (VerfasserIn) , Mier, Walter (VerfasserIn) , Sauter, Max (VerfasserIn) , Exner, Evelyn (VerfasserIn) , Keller, Armin (VerfasserIn) , Krämer, Susanne (VerfasserIn) , Leotta, Karin (VerfasserIn) , Wischnjow, Artjom (VerfasserIn) , Jäger, Dirk (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Krauß, Jürgen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 9 August 2016
In: Cancer letters
Year: 2016, Jahrgang: 381, Heft: 2, Pages: 296-304
ISSN:1872-7980
DOI:10.1016/j.canlet.2016.08.007
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.canlet.2016.08.007
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0304383516304645
Volltext
Verfasserangaben:Tobias Weber, Benedikt Bötticher, Michaela A. E. Arndt, Walter Mier, Max Sauter, Evelyn Exner, Armin Keller, Susanne Krämer, Karin Leotta, Artjom Wischnjow, Ludger Grosse-Hovest, Dirk Strumberg, Dirk Jäger, Hermann-Josef Gröne, Uwe Haberkorn, Gottfried Brem, Jürgen Krauss

MARC

LEADER 00000caa a2200000 c 4500
001 1567009530
003 DE-627
005 20230426064447.0
007 cr uuu---uuuuu
008 180110s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.canlet.2016.08.007  |2 doi 
035 |a (DE-627)1567009530 
035 |a (DE-576)497009536 
035 |a (DE-599)BSZ497009536 
035 |a (OCoLC)1340985627 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weber, Tobias  |e VerfasserIn  |0 (DE-588)1084610361  |0 (DE-627)848568125  |0 (DE-576)456364978  |4 aut 
245 1 0 |a Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model  |c Tobias Weber, Benedikt Bötticher, Michaela A. E. Arndt, Walter Mier, Max Sauter, Evelyn Exner, Armin Keller, Susanne Krämer, Karin Leotta, Artjom Wischnjow, Ludger Grosse-Hovest, Dirk Strumberg, Dirk Jäger, Hermann-Josef Gröne, Uwe Haberkorn, Gottfried Brem, Jürgen Krauss 
264 1 |c 9 August 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.01.2018 
520 |a Radioimmunotherapy is considered as treatment option in recurrent and/or refractory B-cell non-Hodgkin lymphoma (B-NHL). To overcome the dose limiting bone marrow toxicity of IgG-based radioimmunoconjugates (RICs), we modified a humanized diabody with 5-, 10-, or 20-kDa polyethylene glycol (PEG) for CD22-targeted radioimmunotherapy using the low-energy β-emitter lutetium-177 (177Lu). A favorable pharmacokinetic profile was observed for the 10-kDa-PEG-diabody in nude mice being xenografted with subcutaneous human Burkitt lymphoma. Even at high doses of 16 MBq this diabody RIC was well tolerated by NOD Rag1null IL2rγnull (NRG) mice and did not reveal signs of organ long-term toxicity 80 days post injection. Combination therapy of the diabody RIC with unconjugated anti-CD20 Rituximab demonstrated therapeutic efficacy in established disseminated mantle cell lymphoma xenograft models. When compared with the combination of the IgG formatted 177Lu anti-CD22 antibody and Rituximab, dual targeted therapy with the diabody RIC achieved an improved reduction of disease burden in the first nine days following treatment. The data indicate that the PEGylated anti-CD22 diabody may have potential for extending the repertoire of radiopharmaceuticals for the treatment of patients with B-NHL. 
650 4 |a CD22 
650 4 |a Diabody 
650 4 |a Dual-targeting 
650 4 |a Lymphoma 
650 4 |a PEGylation 
650 4 |a Radioimmunotherapy 
700 1 |a Bötticher, Benedikt  |d 1988-  |e VerfasserIn  |0 (DE-588)1150307951  |0 (DE-627)1010589105  |0 (DE-576)497008203  |4 aut 
700 1 |a Arndt, Michaela  |e VerfasserIn  |0 (DE-588)1084612712  |0 (DE-627)848572076  |0 (DE-576)456369635  |4 aut 
700 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
700 1 |a Sauter, Max  |e VerfasserIn  |0 (DE-588)1103516507  |0 (DE-627)86126813X  |0 (DE-576)470642033  |4 aut 
700 1 |a Exner, Evelyn  |e VerfasserIn  |0 (DE-588)1150308427  |0 (DE-627)1010589830  |0 (DE-576)49700903X  |4 aut 
700 1 |a Keller, Armin  |e VerfasserIn  |0 (DE-588)1103035282  |0 (DE-627)860642526  |0 (DE-576)47044018X  |4 aut 
700 1 |a Krämer, Susanne  |e VerfasserIn  |0 (DE-588)1142119386  |0 (DE-627)1001170989  |0 (DE-576)494643684  |4 aut 
700 1 |a Leotta, Karin  |e VerfasserIn  |0 (DE-588)1068657669  |0 (DE-627)82057404X  |0 (DE-576)427989345  |4 aut 
700 1 |a Wischnjow, Artjom  |e VerfasserIn  |0 (DE-588)1128443740  |0 (DE-627)882926349  |0 (DE-576)485914603  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Krauß, Jürgen  |d 1960-  |e VerfasserIn  |0 (DE-588)120665301  |0 (DE-627)70490778X  |0 (DE-576)292329083  |4 aut 
773 0 8 |i Enthalten in  |t Cancer letters  |d Amsterdam [u.a.] : Elsevier Science, 1975  |g 381(2016), 2, Seite 296-304  |h Online-Ressource  |w (DE-627)320434796  |w (DE-600)2004212-7  |w (DE-576)261677926  |x 1872-7980  |7 nnas  |a Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model 
773 1 8 |g volume:381  |g year:2016  |g number:2  |g pages:296-304  |g extent:9  |a Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model 
856 4 0 |u http://dx.doi.org/10.1016/j.canlet.2016.08.007  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0304383516304645  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180110 
993 |a Article 
994 |a 2016 
998 |g 120665301  |a Krauß, Jürgen  |m 120665301:Krauß, Jürgen  |d 910000  |e 910000PK120665301  |k 0/910000/  |p 17  |y j 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 15 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 13 
998 |g 1128443740  |a Wischnjow, Artjom  |m 1128443740:Wischnjow, Artjom  |d 910000  |d 911400  |e 910000PW1128443740  |e 911400PW1128443740  |k 0/910000/  |k 1/910000/911400/  |p 10 
998 |g 1068657669  |a Leotta, Karin  |m 1068657669:Leotta, Karin  |d 910000  |d 911400  |e 910000PL1068657669  |e 911400PL1068657669  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1142119386  |a Krämer, Susanne  |m 1142119386:Krämer, Susanne  |d 910000  |d 911400  |e 910000PK1142119386  |e 911400PK1142119386  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 1103035282  |a Keller, Armin  |m 1103035282:Keller, Armin  |d 910000  |d 911400  |e 910000PK1103035282  |e 911400PK1103035282  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 1150308427  |a Exner, Evelyn  |m 1150308427:Exner, Evelyn  |d 910000  |e 910000PE1150308427  |k 0/910000/  |p 6 
998 |g 1103516507  |a Sauter, Max  |m 1103516507:Sauter, Max  |d 910000  |d 911400  |e 910000PS1103516507  |e 911400PS1103516507  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |e 910000PM12029026X  |e 911400PM12029026X  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 1084612712  |a Arndt, Michaela  |m 1084612712:Arndt, Michaela  |d 910000  |e 910000PA1084612712  |k 0/910000/  |p 3 
998 |g 1150307951  |a Bötticher, Benedikt  |m 1150307951:Bötticher, Benedikt  |d 910000  |e 910000PB1150307951  |k 0/910000/  |p 2 
998 |g 1084610361  |a Weber, Tobias  |m 1084610361:Weber, Tobias  |d 910000  |e 910000PW1084610361  |k 0/910000/  |p 1  |x j 
999 |a KXP-PPN1567009530  |e 2992490849 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"origin":[{"dateIssuedKey":"1975","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedDisp":"1975-"}],"title":[{"title":"Cancer letters","title_sort":"Cancer letters","subtitle":"an international journal providing a forum for original and pertinent contributions in cancer research"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320434796"],"zdb":["2004212-7"],"issn":["1872-7980"]},"part":{"year":"2016","pages":"296-304","text":"381(2016), 2, Seite 296-304","volume":"381","extent":"9","issue":"2"},"note":["Gesehen am 22.01.2020"],"recId":"320434796","disp":"Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse modelCancer letters","language":["eng"],"pubHistory":["1.1975 -"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"note":["Gesehen am 10.01.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1016/j.canlet.2016.08.007"],"eki":["1567009530"]},"physDesc":[{"extent":"9 S."}],"language":["eng"],"title":[{"title_sort":"Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model","title":"Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model"}],"recId":"1567009530","name":{"displayForm":["Tobias Weber, Benedikt Bötticher, Michaela A. E. Arndt, Walter Mier, Max Sauter, Evelyn Exner, Armin Keller, Susanne Krämer, Karin Leotta, Artjom Wischnjow, Ludger Grosse-Hovest, Dirk Strumberg, Dirk Jäger, Hermann-Josef Gröne, Uwe Haberkorn, Gottfried Brem, Jürgen Krauss"]},"origin":[{"dateIssuedDisp":"9 August 2016","dateIssuedKey":"2016"}],"person":[{"given":"Tobias","display":"Weber, Tobias","family":"Weber","role":"aut"},{"given":"Benedikt","display":"Bötticher, Benedikt","family":"Bötticher","role":"aut"},{"display":"Arndt, Michaela","given":"Michaela","family":"Arndt","role":"aut"},{"role":"aut","family":"Mier","given":"Walter","display":"Mier, Walter"},{"role":"aut","given":"Max","display":"Sauter, Max","family":"Sauter"},{"display":"Exner, Evelyn","given":"Evelyn","family":"Exner","role":"aut"},{"role":"aut","family":"Keller","given":"Armin","display":"Keller, Armin"},{"family":"Krämer","given":"Susanne","display":"Krämer, Susanne","role":"aut"},{"role":"aut","display":"Leotta, Karin","given":"Karin","family":"Leotta"},{"family":"Wischnjow","given":"Artjom","display":"Wischnjow, Artjom","role":"aut"},{"role":"aut","family":"Jäger","display":"Jäger, Dirk","given":"Dirk"},{"given":"Uwe","display":"Haberkorn, Uwe","family":"Haberkorn","role":"aut"},{"role":"aut","display":"Krauß, Jürgen","given":"Jürgen","family":"Krauß"}]} 
SRT |a WEBERTOBIAPRECLINICA9201